Free Newsletter
European activists blast Big Pharma for pandemic scare
With governments around the world getting stuck with unused supplies of swine flu vaccine, it was almost a sure bet that at some point Big Pharma would be attacked for orchestrating a global panic attack in order to sell billions of dollars worth of vaccine.
So it's no great surprise to hear that a group of activists in the Parliamentary Assembly of the Council of Europe plan to investigate if the vaccine companies pressured the World Health Organization to declare the first pandemic in more than 40 years. Dr. Wolfgang Wodarg, chairman the PACE Health Committee, called it "one of the greatest medicine scandals of the century."
"In order to promote their patented drugs and vaccines against flu, pharmaceutical companies have influenced scientists and official agencies, responsible for public health standards, to alarm governments worldwide," reads the statement. "They have made them squander tight health care resources for inefficient vaccine strategies and needlessly exposed millions of healthy people to the risk of unknown side-effects of insufficiently tested vaccines."
Most of the world's government health agencies, meanwhile, are continuing to plead with people to get vaccinated. Many people, though, are either ignoring the swine flu threat or avoiding the vaccine due to unsubstantiated fears of side effects.
- here's the story from PharmaTimes
Related Articles:
H1N1 oversupply puts earnings at 'modest' risk
France sells flu shots; Germany plans returns
Germany, Spain want to return unused H1N1 vaccine
Vaccine demand plunges as H1N1 pandemic fears fade
Comments
Typical bureaucrats. They prodded the world that the end was near unless we all got vaccinated. Now they have to face the music for their stupidity. So what do they do? They look for the drug companies as the whipping boy to take the heat off their own misjudgement----once again. Dump all these professional politicians.
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact



